MOC Cancer Care & Research Centre launches CAR-T Cell Therapy

New Delhi: MOC Cancer Care & Research Centre has unveiled CAR-T Cell Therapy, a treatment now available to patients in India. This innovative therapy, already proven effective in treating certain blood cancers like leukemia, myeloma, and lymphomas in other countries, offers new hope for patients in India.

CAR-T Cell Therapy marks a more accessible and affordable option for Indian patients. By expanding access to this therapy, MOC Cancer Care & Research Centre seeks to improve outcomes for individuals facing challenging cancers and those who have exhausted other treatment options.

Dr. Suraj Chiraniya, a prominent hemato-oncologist and BMT specialist at MOC, highlighted, “Early diagnosis is not just beneficial; it can be life-saving. Our campaign is dedicated to empowering the public with knowledge about the symptoms of blood cancer and the transformative treatment options available, including bone marrow and stem cell transplants. CAR-T cell therapy at MOC, a revolutionary advancement harnesses the power of the patient’s own immune system to combat cancer more effectively than ever before.”

Dr. Ashray Kole, a leading oncologist at MOC, commented, “CAR-T Cell Therapy represents a paradigm shift in the way we treat cancer. By making these advanced therapies more accessible and affordable, we aim to ensure that a greater number of patients can benefit from these life-saving treatments and have a fighting chance against even the most aggressive forms of cancer.”

In conjunction with the launch of CAR-T Cell Therapy, MOC Cancer Care & Research Centre is also promoting Blood Cancer Awareness Month. This campaign is designed to highlight the challenges faced by blood cancer patients and the potential of advanced therapies. It aims to raise awareness, support early detection, and encourage ongoing research to enhance patient outcomes.